Identification and functional analysis of a novel bradykinin inhibitory peptide in the venoms of New World Crotalinae pit vipers

Biochemical and Biophysical Research Communications

Volumn 338, Issue 3, 2005, Pages 1587-1592

  James Graham, Robert Leslie ^a   Graham, Ciaren ^a   McClean, Stephen ^a   Chen, Tianbao ^c   O'Rourke, Martin ^c   Hirst, David ^c   Theakston, David ^b   Shaw, Chris ^c  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Bradykinin; Mass spectrometry; Peptide; Snake venom; Vasoconstriction

Indexed keywords

BRADYKININ; PEPTIDE; SNAKE VENOM;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DATA BASE; GEL PERMEATION CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN PURIFICATION; REVERSED PHASE LIQUID CHROMATOGRAPHY; SNAKE; SOUTH AMERICA;

AMINO ACID SEQUENCE; ANIMALS; BRADYKININ; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROTALID VENOMS; MALE; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; RATS, WISTAR; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TAIL; VIPERIDAE;

AGKISTRODON BILINEATUS; CROTALINAE; CROTALUS DURISSUS; CROTALUS DURISSUS TERRIFICUS; CROTALUS VIRIDIS VIRIDIS; LACHESIS MUTA;

EID: 27744545281     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.10.130     Document Type: Article

References (21)

1. A. Harvey From venom to toxin to drug? Proc. R. Soc. Edinb. [Biol Sci]. 99 1992 55 65
2. A.L. Harvey, K.N. Bradley, S.A. Cochran, E.G. Rowan, J.A. Pratt, J.A. Quillfeldt, and D.A. Jerusalinsky What can toxins tell us for drug discovery? Toxicon 36 1998 1635 1640
3. S.A. Brown, and P. Alewood Venom as a source of useful biologically active molecules Emerg. Med. (Fremantle) 13 2001 389 390
4. M.A. Ondetti, B. Rubin, and D.W. Cushman Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents Science 196 1977 441 444
5. M.A. Ondetti, N.J. Williams, E.F. Sabo, J. Plusec, E.R. Weaver, and O. Cocy Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis Biochemistry 10 1971 4033 4039
6. S.H. Ferreira, D.C. Bartelt, and L.J. Greene Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom Biochemistry 9 1970 2583 2593
7. S.H. Ferreira, L.H. Greene, V.A. Alabaster, Y.S. Bakhle, and J.R. Vane Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme Nature 225 1970 379 380
8. G.W. Albers, P. Amarenco, J.D. Easton, R.L. Sacco, and P. Teal Antithrombotic and thrombolytic therapy for ischemic stroke Chest 119 2001 300S 320S
9. W. Burkhart, G.F.H. Smith, J.-L. SU, I. Parikh, and H. LeVine III Amino acid sequence determination of Ancrod, the thrombin-like [alpha]-fibrinogenase from the venom of Akistrodon rhodostoma FEBS Lett. 297 1992 297 301
10. F.J. Obst, K. Richter, and U. Jacob The Completely Illustrated Atlas of Reptiles and Amphibians for the Terrarium 1998 T.F.H. Publications
11. F.E. Russell, F.G. Walter, T.A. Bey, and M.C. Fernandez Snakes and snakebite in Central America Toxicon 35 1997 1469 1522
12. 2+]i smooth muscle Annu. Rev. Physiol. 51 1989 315 329
13. V.M. Doyle, and U.T. Ruegg Vasopressin induced production of inositol trisphosphate and calcium efflux in a smooth muscle cell line Biochem. Biophys. Res. Commun. 131 1985 469 476
14. A.P. Somlyo, and B. Himpens Cell calcium and its regulation in smooth muscle FASEB J. 3 1989 2266 2276
15. D.M. Burns, M.W. Ruddock, M.D. Walker, J.M. Allen, G.D. Kennovin, and G.D. Hirst Nicotinamide-inhibited vasoconstriction: lack of dependence on agonist signalling pathways Eur. J. Pharmacol. 374 1999 213 220
16. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526
17. D.G. Hirst, G.D. Kennovin, and F.W. Flitney The radiosensitizer nicotinamide inhibits arterial vasoconstriction Br. J. Radiol. 67 1994 795 799
18. E. Kochva, C.C. Viljoen, and D.P. Botes A new type of toxin in the venom of snakes of the genus Atractaspis (Atractaspidinae) Toxicon 20 1982 581 592
19. M.A.F. Hayashi, C. Ligny-lemaire, Z. Wollberg, M. Wery, A. Galat, T. Ogawa, B.H. Muller, H. Lamthanh, Y. Doljansky, and A. Bdolah Long-sarafotoxins: characterization of a new family of endothelin-like peptides Peptides 25 2004 1243 1251
20. M. Clozel, V. Breu, G.A. Gray, B. Kalina, B.-M. Loffler, K. Burri, J.M. Cassal, M. Muller, W. Neidhart, and H. Ramuz Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist J. Pharmacol. Exp. Ther. 270 1994 228 235
21. G.A. Gray, and D.J. Webb The endothelin system and its potential as a therapeutic target in cardiovascular disease Pharmacol. Ther. 72 1996 109 148